Form 4 holding
Chief Scientific Officer
Regulus Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 100,000
- Estimated value
- $119,060
- Report date
- 01 Mar 2022
- Price
- $1.19
- Ownership
- Direct
Denis Drygin
Insider Reports History
- Location
- San Diego, CA
- Reporting signature
- Christopher Aker, Attorney in Fact
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
SEC record
SEC evidence
Holdings reported by Denis Drygin:
Insider Reports Filed by Denis Drygin
4
RGLS
Regulus Therapeutics Inc.
- Report period
- 01 Mar 2022
- Transactions
- 1
- Transaction value
- +$17,638
- Filing time
- 01 Mar 2022, 16:58
- Role
- Chief Scientific Officer
- Next action
- Open filing details
4
RGLS
Regulus Therapeutics Inc.
- Report period
- 04 Feb 2022
- Transactions
- 1
- Transaction value
- +$5,362
- Filing time
- 07 Feb 2022, 16:09
- Role
- Chief Scientific Officer
- Next action
- Open filing details
4
RGLS
Regulus Therapeutics Inc.
- Report period
- 12 Jan 2022
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 26 Jan 2022, 15:14
- Role
- Chief Scientific Officer
- Next action
- Open filing details